High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.2M
$3,207,700
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| VCYT |
VERACYTE, INC.
|
CFO
10b5-1 Sell
|
2026-03-04 | $662,869x2 | S | Form 4 |
|
VCYT
S
VERACYTE, INC.
Leite John
• Officer • Chief Commercial Officer-CLIA
10b5-1 Sell
2026-03-04
$185,083
|
||||||
| VCYT |
VERACYTE, INC.
|
Officer • Chief Commercial Officer-CLIA
10b5-1 Sell
|
2026-03-04 | $185,083 | S | Form 4 |
|
VCYT
S
VERACYTE, INC.
McGuire Annie
• Officer • SVP, General Counsel
10b5-1 Sell
2026-03-04
$236,725x2
|
||||||
| VCYT |
VERACYTE, INC.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2026-03-04 | $236,725x2 | S | Form 4 |
| VCYT |
VERACYTE, INC.
|
CEO
10b5-1 Sell
|
2026-03-04 | $1,637,594Largex2 | S | Form 4 |
|
VCYT
S
VERACYTE, INC.
Febbo Phillip G.
• Officer • Chief Scientific & Med Officer
10b5-1 SellΔOwn -10.3%
2026-03-02
$485,429
|
||||||
| VCYT |
VERACYTE, INC.
|
Officer • Chief Scientific & Med Officer
10b5-1 SellΔOwn -10.3%
|
2026-03-02 | $485,429 | S | Form 4 |